Corient Private Wealth’s Intuitive Surgical ISRG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$158M Sell
336,763
-563,517
-63% -$285M 0.23% 91
2025
Q4
$408M Buy
900,280
+578,497
+180% +$308M 0.27% 80
2025
Q3
$144M Buy
321,783
+18,112
+6% +$8.69M 0.23% 91
2025
Q2
$165M Buy
303,671
+123,766
+69% +$64.7M 0.22% 90
2025
Q1
$89.1M Sell
179,905
-7,612
-4% -$4.21M 0.15% 152
2024
Q4
$97.9M Sell
187,517
-8,087
-4% -$4.21M 0.16% 140
2024
Q3
$96.1M Buy
195,604
+2,680
+1% +$1.25M 0.15% 144
2024
Q2
$85.8M Buy
192,924
+33,398
+21% +$13.3M 0.15% 147
2024
Q1
$63.7M Buy
159,526
+26
+0% +$9.82K 0.11% 187
2023
Q4
$53.8M Buy
159,500
+12,569
+9% +$3.75M 0.1% 208
2023
Q3
$43M Sell
146,931
-1,348
-0.9% -$421K 0.1% 221
2023
Q2
$50.7M Buy
148,279
+4,036
+3% +$1.22M 0.12% 182
2023
Q1
$36.8M Buy
144,243
+65,678
+84% +$16.2M 0.1% 201
2022
Q4
$20.9M Buy
+78,565
New +$19.2M 0.08% 259

Other funds holding ISRG

Corient Private Wealth's ISRG Position: Q1 2026 in Review

Corient Private Wealth reduced its Intuitive Surgical (ISRG) stake by 63% in Q1 2026, selling an estimated $285M and leaving 336,763 shares worth $158M. The position accounts for 0.23% of the portfolio, ranked #91.

Corient Private Wealth first reported a position in ISRG in Q4 2022 and has held it in 14 quarters since. The position peaked at $408M in Q4 2025. 2,303 funds tracked by Wall St. Rank hold ISRG as of Q1 2026.

  • Corient Private Wealth held 336,763 shares of Intuitive Surgical worth $158M as of Q1 2026.
  • Corient Private Wealth sold 563,517 Intuitive Surgical shares in Q1 2026, an estimated $285M.
  • Intuitive Surgical made up 0.23% of Corient Private Wealth's portfolio in Q1 2026, its #91 holding.
  • Corient Private Wealth first reported a position in Intuitive Surgical in Q4 2022 and has held it in 14 quarters since.
  • Corient Private Wealth's Intuitive Surgical position peaked at $408M in Q4 2025.
  • 2,303 funds tracked by Wall St. Rank held Intuitive Surgical as of Q1 2026.

Based on Corient Private Wealth's 13F filing for Q1 2026, filed 15 May 2026.